+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Nanobiotechnology Market by Product, Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 196 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5889522
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Nanobiotechnology Market grew from USD 3.49 billion in 2023 to USD 4.11 billion in 2024. It is expected to continue growing at a CAGR of 16.04%, reaching USD 9.91 billion by 2030.

Nanobiotechnology is a field at the intersection of nanotechnology and biotechnology, utilizing nanoscale tools and techniques for applications in medicine, agriculture, and environmental management. It covers diagnostics, drug delivery systems, and regenerative medicine, with a focus on enhancing product performance at molecular or atomic levels. The necessity for nanobiotechnology arises from its potential to revolutionize healthcare by enabling precise interventions at the cellular level, providing sustainable agricultural solutions, and addressing environmental challenges through nanoscale innovations.

The market is fueled by increased R&D investments, technological advancements, and the rising demand for personalized medicine. Key growth factors include the growing prevalence of chronic diseases, the need for sustainable agricultural practices, and regulatory support for nanotechnology applications. Recent opportunities can be seen in the development of nanoscale biosensors for early disease detection and smart drug delivery systems-providing precision therapies with reduced side effects. Collaborations between academia and industry, alongside government funding, further drive innovation and commercialization.

However, market growth is hampered by significant challenges such as high costs of R&D, potential environmental and health risks associated with nanomaterials, and the lack of standardized regulations, which can slow down product development and market entry. Addressing these limitations requires strategic partnerships, increased funding, and a focus on developing environmentally friendly and safe nanomaterials.

Key areas for innovation include the creation of multifunctional nanoparticles for theranostics, advanced nanocarriers for targeted drug delivery, and nanomaterials for biosensing applications. To remain competitive, companies should focus on enhancing their R&D capabilities and forming strategic alliances for technological advancements and quicker market penetration. The nanobiotechnology market is characterized by rapid growth, intense competition, and the need for continuous innovation, offering ample opportunities for businesses to lead in technology development and deployment.

Understanding Market Dynamics in the Nanobiotechnology Market

The Nanobiotechnology Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing the use of nanobiotechnology for improving healthcare practices
    • Rising drug discovery and development processes
    • Utilization of nanotechnology for development of sustainable biomaterials
  • Market Restraints
    • Ethical and environmental issues associated with nanobiotechnology
  • Market Opportunities
    • Increasing research in genomics and proteomics
    • Emerging use of nanobiotechnology in agriculture
  • Market Challenges
    • Regulations governing nanotechnology products

Exploring Porter’s Five Forces for the Nanobiotechnology Market

Porter’s Five Forces framework further strengthens the insights of the Nanobiotechnology Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Nanobiotechnology Market

External macro-environmental factors deeply influence the performance of the Nanobiotechnology Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Nanobiotechnology Market

The Nanobiotechnology Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Nanobiotechnology Market

The Nanobiotechnology Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Nanobiotechnology Market

The Nanobiotechnology Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Nanobiotechnology Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Agilent Technologies, Inc., Analog Devices, Inc., ANSELL LTD., Arkema S.A., Bruker Corporation, DuPont de Nemours, Inc., Eurofins Scientific SE, Evonik Industries AG, Honeywell International Inc., Merck KGaA, Nanoscience Instruments, Inc., Nanospan Inc., Sioen Industries NV, Texas Instruments Incorporated, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Nanobiotechnology Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Nano-Enabled Drugs
    • Nanodevices
    • Nanoparticles
    • Nanotechnology Tools
  • Application
    • Agriculture
    • Cancer Treatment
    • Diagnostics
    • Drug Delivery
    • Environmental Monitoring
    • Regenerative Medicines
    • Therapeutics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing the use of nanobiotechnology for improving healthcare practices
5.1.1.2. Rising drug discovery and development processes
5.1.1.3. Utilization of nanotechnology for development of sustainable biomaterials
5.1.2. Restraints
5.1.2.1. Ethical and environmental issues associated with nanobiotechnology
5.1.3. Opportunities
5.1.3.1. Increasing research in genomics and proteomics
5.1.3.2. Emerging use of nanobiotechnology in agriculture
5.1.4. Challenges
5.1.4.1. Regulations governing nanotechnology products
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Nanobiotechnology Market, by Product
6.1. Introduction
6.2. Nano-Enabled Drugs
6.3. Nanodevices
6.4. Nanoparticles
6.5. Nanotechnology Tools
7. Nanobiotechnology Market, by Application
7.1. Introduction
7.2. Agriculture
7.3. Cancer Treatment
7.4. Diagnostics
7.5. Drug Delivery
7.6. Environmental Monitoring
7.7. Regenerative Medicines
7.8. Therapeutics
8. Americas Nanobiotechnology Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Nanobiotechnology Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Nanobiotechnology Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. Market Share Analysis, 2023
11.2. FPNV Positioning Matrix, 2023
11.3. Competitive Scenario Analysis
11.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. NANOBIOTECHNOLOGY MARKET RESEARCH PROCESS
FIGURE 2. NANOBIOTECHNOLOGY MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL NANOBIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL NANOBIOTECHNOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL NANOBIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. AMERICAS NANOBIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 11. AMERICAS NANOBIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. UNITED STATES NANOBIOTECHNOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 13. UNITED STATES NANOBIOTECHNOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. ASIA-PACIFIC NANOBIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. ASIA-PACIFIC NANOBIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA NANOBIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA NANOBIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. NANOBIOTECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 19. NANOBIOTECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. NANOBIOTECHNOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL NANOBIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL NANOBIOTECHNOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL NANOBIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. NANOBIOTECHNOLOGY MARKET DYNAMICS
TABLE 7. GLOBAL NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL NANOBIOTECHNOLOGY MARKET SIZE, BY NANO-ENABLED DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL NANOBIOTECHNOLOGY MARKET SIZE, BY NANODEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL NANOBIOTECHNOLOGY MARKET SIZE, BY NANOPARTICLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL NANOBIOTECHNOLOGY MARKET SIZE, BY NANOTECHNOLOGY TOOLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL NANOBIOTECHNOLOGY MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL NANOBIOTECHNOLOGY MARKET SIZE, BY CANCER TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL NANOBIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL NANOBIOTECHNOLOGY MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL NANOBIOTECHNOLOGY MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL NANOBIOTECHNOLOGY MARKET SIZE, BY REGENERATIVE MEDICINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL NANOBIOTECHNOLOGY MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS NANOBIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 25. BRAZIL NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. CANADA NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 28. CANADA NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. MEXICO NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 30. MEXICO NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES NANOBIOTECHNOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 34. ASIA-PACIFIC NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 35. ASIA-PACIFIC NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. ASIA-PACIFIC NANOBIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 37. AUSTRALIA NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 38. AUSTRALIA NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. CHINA NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 40. CHINA NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 41. INDIA NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 42. INDIA NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. INDONESIA NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 44. INDONESIA NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. JAPAN NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 46. JAPAN NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. MALAYSIA NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 48. MALAYSIA NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. PHILIPPINES NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 50. PHILIPPINES NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. SINGAPORE NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 52. SINGAPORE NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. SOUTH KOREA NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 54. SOUTH KOREA NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. TAIWAN NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 56. TAIWAN NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. THAILAND NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. THAILAND NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. VIETNAM NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 60. VIETNAM NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. EUROPE, MIDDLE EAST & AFRICA NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62. EUROPE, MIDDLE EAST & AFRICA NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. EUROPE, MIDDLE EAST & AFRICA NANOBIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 64. DENMARK NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 65. DENMARK NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. EGYPT NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 67. EGYPT NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. FINLAND NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 69. FINLAND NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. FRANCE NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 71. FRANCE NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. GERMANY NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 73. GERMANY NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. ISRAEL NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 75. ISRAEL NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. ITALY NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 77. ITALY NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. NETHERLANDS NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 79. NETHERLANDS NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. NIGERIA NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 81. NIGERIA NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. NORWAY NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 83. NORWAY NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. POLAND NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 85. POLAND NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. QATAR NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 87. QATAR NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. RUSSIA NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 89. RUSSIA NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. SAUDI ARABIA NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 91. SAUDI ARABIA NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. SOUTH AFRICA NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 93. SOUTH AFRICA NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. SPAIN NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 95. SPAIN NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. SWEDEN NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 97. SWEDEN NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. SWITZERLAND NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. SWITZERLAND NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. TURKEY NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 101. TURKEY NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. UNITED ARAB EMIRATES NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 103. UNITED ARAB EMIRATES NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. UNITED KINGDOM NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 105. UNITED KINGDOM NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. NANOBIOTECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2023
TABLE 107. NANOBIOTECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Nanobiotechnology Market, which are profiled in this report, include:
  • 3M Company
  • Agilent Technologies, Inc.
  • Analog Devices, Inc.
  • ANSELL LTD.
  • Arkema S.A.
  • Bruker Corporation
  • DuPont de Nemours, Inc.
  • Eurofins Scientific SE
  • Evonik Industries AG
  • Honeywell International Inc.
  • Merck KGaA
  • Nanoscience Instruments, Inc.
  • Nanospan Inc.
  • Sioen Industries NV
  • Texas Instruments Incorporated
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...

Table Information